Inhibition of another anti-apoptotic BCL-2 family member, BCL-xL, has been shown to increase TRAIL-mediated apoptosis in breast cancer cells including TNBC in preclinical models [55]. The gene discussed is TNFSF10; the disease is breast carcinoma.